View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
September 21, 2018updated 23 Dec 2019 10:54am

Innovate UK funds AI drug discovery platform

Innovate UK has been awarded a grant to support the development of an artificial intelligence (AI) drug discovery project by Optibrium, Intellegens and Medicines Discovery Catapult.

Innovate UK has been awarded a grant to support the development of an artificial intelligence (AI) drug discovery project by Optibrium, Intellegens and Medicines Discovery Catapult.

Free Report
img

Spot leading innovative companies with GlobalData’s Innovation Scorecard

Innovation remains a necessity in a disruptive ecosystem, as continuous innovation allows companies to adapt, evolve, and grow through disruption. Using our in-house alternative datasets, we are excited to launch GlobalData’s Innovation Scorecard. This scorecard will allow clients to rank 3,500+ companies on their innovation activity, impact, and disruptive potential across geography, sector, and theme. The scorecard provides a data-driven framework to rank leading companies on the potential of their intellectual property (IP) portfolio. GlobalData’s Innovation Scorecard focuses not only on the activity of innovation in the organization but also on its impact and disruptive potential using the 3I framework: Intensity, Impact, and Ingenuity. The tool helps clients to identify the most innovative companies that are disruptive leaders and challengers and can create alpha for their portfolio using the insights driven by 19+ high-value KPIs. Download our report to find out more about this innovative tool. Key findings derived from this tool include:
  • Alphabet, Tencent, and Qualcomm are the top three innovative companies in the last 10 years
  • The scorecard finds Technology & Communications and Pharma & Healthcare as the two main sectors driving innovation
  • Loreal placed as ‘Disruptive Leader’ in the Consumer sector, while Revlon has been identified as a traditional laggard
  • Companies such as Etsy and H&M are challenging retail ‘Disruptive Leaders’ Amazon and Walmart
by GlobalData
Enter your details here to receive your free Report.

Optibrium focuses on development of software to enhance drug discovery, Intellegens is a spin out of the University of Cambridge working on deep learning and Medicines Discovery Catapult is the national centre of applied research and development (R&D) expertise.

Under the £1m project, the companies will utilise the Innovate UK grant to co-develop a next generation AI drug discovery platform using new deep learning techniques.

These new AI techniques will be based on Optibrium’s StarDrop software and Intellegens’ Alchemite deep learning toolkit.

The platform will be designed to learn from complex data and predict the absorption, distribution, metabolism, excretion and toxicity (ADMET) of potential new medicines.

Such predictions are expected to provide guidance for scientists when designing and testing new drug candidates.

Optibrium, Intellegens and Medicines Discovery Catapult aim to offer better insights into the interaction of a drug with the body in order to enhance the efficiency and productivity of drug discovery.

Optibrium CEO Matthew Segall said: “We will apply cutting edge deep learning methods and new data to address important challenges in drug optimisation.

“The grant from Innovate UK represents an important milestone for the advancement of informatics and data science.”

“The funding from Innovate UK is important validation of our project team’s expertise and the impact it will have on the industry’s efficiency and productivity.”

Medicines Discovery Catapult Chief Informatics Officer Professor John Overington said: “At Medicines Discovery Catapult we apply innovation, working alongside UK SMEs to drive the development and adoption of new approaches for the discovery and early development of new medicines.

“This collaborative R&D activity will allow us to do just that and the grant from Innovate UK represents an important milestone for the advancement of informatics and data science.”

Innovate UK has also awarded co-funding to Storm ID, NHS Greater Glasgow & Clyde and KenSci for the development of a new care pathway to help chronic obstructive pulmonary disease (COPD) patients.

This project is set to use remote monitoring and AI-based preventative approaches to minimise emergency hospital admissions among COPD patients who are at the highest risk.

The machine learning algorithms will remotely monitor patients’ symptoms, physiology and treatment at home, to provide clinical decision support for patients at high risk of an exacerbation.

Related Companies

Free Report
img

Spot leading innovative companies with GlobalData’s Innovation Scorecard

Innovation remains a necessity in a disruptive ecosystem, as continuous innovation allows companies to adapt, evolve, and grow through disruption. Using our in-house alternative datasets, we are excited to launch GlobalData’s Innovation Scorecard. This scorecard will allow clients to rank 3,500+ companies on their innovation activity, impact, and disruptive potential across geography, sector, and theme. The scorecard provides a data-driven framework to rank leading companies on the potential of their intellectual property (IP) portfolio. GlobalData’s Innovation Scorecard focuses not only on the activity of innovation in the organization but also on its impact and disruptive potential using the 3I framework: Intensity, Impact, and Ingenuity. The tool helps clients to identify the most innovative companies that are disruptive leaders and challengers and can create alpha for their portfolio using the insights driven by 19+ high-value KPIs. Download our report to find out more about this innovative tool. Key findings derived from this tool include:
  • Alphabet, Tencent, and Qualcomm are the top three innovative companies in the last 10 years
  • The scorecard finds Technology & Communications and Pharma & Healthcare as the two main sectors driving innovation
  • Loreal placed as ‘Disruptive Leader’ in the Consumer sector, while Revlon has been identified as a traditional laggard
  • Companies such as Etsy and H&M are challenging retail ‘Disruptive Leaders’ Amazon and Walmart
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology